exelixis - Robuta Search

https://www.barchart.com/stocks/quotes/EXEL/insider-trades EXEL Insider Trades for Exelixis Stock - Barchart.com Insider trades for Exelixis Inc (EXEL): buy, sell, award and other transactions for EXEL insiders. insider trades exel stock barchart https://www.barchart.com/stocks/quotes/EXEL/technical-chart EXEL Snapshot Chart for Exelixis Stock - Barchart.com Technical stocks chart with latest price quote for Exelixis Inc, with technical analysis, latest news, and opinions. exel snapshot chart stock https://www.biospace.com/press-releases/exelixis-to-webcast-fireside-chats-as-part-of-investor-conferences-in-may-2025 Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May 2025 - BioSpace https://www.barchart.com/stocks/quotes/EXEL/opinion/20-100-Day-MA-Crossover/strategy-charts EXEL Barchart Opinion for Exelixis Stock - Barchart.com Trading Signals for Exelixis Inc with Buy, Sell, Hold recommendations, technical analysis, and trading strategy. exel barchart opinion stock https://informaconnect.com/medicaid-drug-rebate-program-summit-mdrp/speakers/darnell-turner/ Darnell Turner - Exelixis Inc | Medicaid Drug Rebate Program (MDRP) Summit 2026 Speaker The Largest and Most Authoritative Event for Government Pricing, Rebates and Regulation | The MDRP Summit provides unparalleled access to the government... medicaid drug rebate program darnell turner exelixis inc https://www.researchandmarkets.com/reports/1292004/exelixis_inc_exel_financial_and_strategic Exelixis Inc (EXEL) - Financial and Strategic SWOT Analysis Review exelixis inc swot analysis financial strategic review https://www.insidermonkey.com/blog/hedge-fund-and-insider-trading-news-bill-ackman-ken-griffin-peconic-partners-exelixis-inc-exel-california-resources-corp-crc-and-more-1309163/ Hedge Fund and Insider Trading News: Bill Ackman, Ken Griffin, Peconic Partners, Exelixis, Inc.... Mega-billionaire Ken Griffin Wants to Own Our World (TheInformation. https://www.nasdaq.com/market-activity/stocks/exel/institutional-holdings Exelixis, Inc. Common Stock (EXEL) Institutional Holdings | Nasdaq Find the latest institutional holdings data for Exelixis, Inc. Common Stock (EXEL) including shareholders, ownership summaries, and holding activities at... exelixis inc common stock institutional holdings nasdaq https://www.barchart.com/stocks/quotes/EXEL/performance EXEL Performance Report for Exelixis Stock - Barchart.com performance report exel stock barchart https://www.flexjobs.com/remote-jobs/company/exelixis Exelixis - Remote Work From Home Jobs & Careers | FlexJobs Find remote work from home jobs and careers with Exelixis. Get a better remote job search with FlexJobs today! work from home jobs exelixis remote careers flexjobs https://www.businesswire.com/news/home/20230820936777/en/Exelixis-and-Ipsen-Announce-Positive-Results-from-Phase-3-CONTACT-02-Pivotal-Trial-Evaluating-Cabozantinib-in-Combination-with-Atezolizumab-in-Metastatic-Castration-Resistant-Prostate-Cancer Exelixis and Ipsen Announce Positive Results from Phase 3 CONTACT-02 Pivotal Trial Evaluating... Exelixis, Inc. (Nasdaq: EXEL) and Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the global phase 3 CONTACT-02 pivotal trial met one of two primary e... https://www.barchart.com/stocks/quotes/EXEL/options-history EXEL Options Overview History for Exelixis Stock - Barchart.com Provides important summary options statistics to provide a forward looking indication of investors' sentiment, going back up to two years. options overview exel history stock barchart https://investingnews.com/tag/exelixis Exelixis | INN exelixis inn https://www.prnewswire.com/news-releases/sairopa-reports-research-milestones-achieved-in-partnership-with-exelixis-totalling-35-million-from-consecutive-clinical-milestone-payments-in-2024-302330478.html Sairopa reports research milestones achieved in partnership with Exelixis, totalling $35 Million... /PRNewswire/ -- Sairopa B.V., today announced it has achieved a milestone event in its exclusive clinical development and option agreement with Exelixis,... in partnership with research milestones https://www.law360.com/articles/1890285/judge-backs-exelixis-cancer-drug-patent-claims Judge Backs Exelixis Cancer Drug Patent Claims - Law360 A Delaware federal judge on Tuesday rejected invalidity arguments against three Exelixis patents that MSN Laboratories Private Ltd. said it would be infringing... cancer drug patent claims judge backs exelixis https://www.barchart.com/stocks/quotes/EXEL/opinion/Trend-Seeker/strategy-charts EXEL Barchart Opinion for Exelixis Stock - Barchart.com Trading Signals for Exelixis Inc with Buy, Sell, Hold recommendations, technical analysis, and trading strategy. exel barchart opinion stock https://www.biospace.com/exelixis-and-arcus-biosciences-announce-clinical-trial-collaboration-to-evaluate-zanzalintinib-in-combination-with-ab521-in-patients-with-advanced-renal-cell-carcinoma Exelixis and Arcus Biosciences Announce Clinical Trial Collaboration to Evaluate Zanzalintinib in... Dec 5, 2023 - Exelixis, Inc. and Arcus Biosciences announced that the companies have entered into a clinical trial collaboration for STELLAR-009, a phase 1b/2 trial... clinical trial https://www.barchart.com/stocks/quotes/EXEL/options-data EXEL Options Data Summary for Exelixis Inc - Barchart.com Exelixis Inc (EXEL) Options Summary, Volatility, Trend, Expected Move, and Put/Call Ratios to spot long and short option trends. options data exelixis inc summary barchart https://www.finanzen.net/orderbuch/exelixis EXELIXIS AKTIE Orderbuch Xetra | Order-Lage | 936718 exelixis aktie orderbuch xetra lage https://www.fool.com/investing/2017/08/09/exelixis-inc-continued-its-winning-ways-and-rose-1.aspx Exelixis, Inc. Continued Its Winning Ways and Rose 10% in July Thanks to These 3 Catalysts | The... Aug 9, 2017 - Can nothing slow down this biotech rocket? https://robinhood.com/us/en/stocks/EXEL/ Exelixis: EXEL Stock Price Quote & News | Robinhood View the real-time EXEL price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold... stock price exelixis quote news robinhood https://www.macrotrends.net/stocks/charts/EXEL/exelixis/current-ratio Exelixis Current Ratio 2012-2026 | EXEL | MacroTrends Current and historical current ratio for Exelixis (EXEL) from 2012 to 2026. Current ratio can be defined as a liquidity ratio that measures a company's ability... current ratio exelixis 2012 2026 macrotrends https://www.barchart.com/stocks/quotes/EXEL/opinion/20-50-Day-MA-Crossover/strategy-charts EXEL Barchart Opinion for Exelixis Stock - Barchart.com Trading Signals for Exelixis Inc with Buy, Sell, Hold recommendations, technical analysis, and trading strategy. exel barchart opinion stock https://support.exelixis.fr/ Shop.Exelixis shop exelixis https://www.biospace.com/press-releases/exelixis-announces-fourth-quarter-and-fiscal-year-2024-financial-results-and-provides-corporate-update Exelixis Announces Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Corporate... fiscal year 2024 fourth quarter https://www.exelixis.fr/ Spécialiste faisceau moteur | Exelixis Jun 29, 2026 - Exelixis, spécialiste faisceau moteur, conçoit des solutions fiables et adaptées à votre projet automobile sur mesure. faisceau moteur exelixis https://www.barchart.com/stocks/quotes/EXEL/put-call-ratios EXEL Put/Call Ratio for Exelixis Stock - Barchart.com Exelixis Inc (EXEL) Option Put/Call Volume, Put/Call Open Interest, and Put/Call Ratios to spot long and short option trends. put call ratio exel stock barchart https://www.fiercebiotech.com/biotech/exelixis-forks-over-25m-licensing-rights-potential-bioinvent-antibody-drug-targets Exelixis signs on $25M to check out BioInvent's antibody library Jun 16, 2022 - Exelixis will pay $25 million upfront for the right to check out three drug targets from BioInvent's library. check out exelixis signs 25m https://www.barchart.com/stocks/quotes/EXEL/covered-calls EXEL Covered Call Options for Exelixis Stock - Barchart.com covered call exel options stock barchart https://www.upguard.com/security-report/exelixis Exelixis Security Rating, Vendor Risk Report, and Data Breaches | UpGuard Compare Exelixis's security performance with other companies. Learn about data breaches, cyber attacks, and security incidents involving Exelixis. security rating vendor risk data breaches exelixis report https://theorg.com/org/exelixis/org-chart/christopher-j-senner Christopher J. Senner - EVP, CFO at Exelixis | The Org christopher j senner evp cfo https://theorg.com/org/exelixis/org-chart/dana-t-aftab Dana T. Aftab - EVP, Discovery & Translational Research & Chief Scientific Officer at Exelixis |... chief scientific officer translational research https://www.biospace.com/exelixis-inc-reports-long-term-phase-1-results-in-a-cohort-of-medullary-thyroid-cancer-patients-treated-with-xl184-to-be-presented-at-american-socie Exelixis, Inc. Reports Long-Term Phase 1 Results In A Cohort Of Medullary Thyroid Cancer Patients... https://finviz.com/quote?t=EXEL&ty=oc&ta=0&p=d EXEL - Exelixis Inc Options EXEL - Exelixis Inc - Stock screener for investors and traders, financial visualizations. exelixis inc options https://www.barchart.com/stocks/quotes/EXEL/opinion/20-200-Day-MA-Crossover/strategy-charts EXEL Barchart Opinion for Exelixis Stock - Barchart.com Trading Signals for Exelixis Inc with Buy, Sell, Hold recommendations, technical analysis, and trading strategy. exel barchart opinion stock https://www.barchart.com/stocks/quotes/EXEL/time-and-sales EXEL Time & Sales for Exelixis Stock - Barchart.com exel time sales stock barchart https://www.fool.com/earnings/call-transcripts/2024/05/01/exelixis-exel-q1-2024-earnings-call-transcript/ Exelixis (EXEL) Q1 2024 Earnings Call Transcript | The Motley Fool May 1, 2024 - EXEL earnings call for the period ending March 31, 2024. earnings call transcript q1 2024 the motley exelixis fool https://www.barchart.com/stocks/quotes/EXEL/trading-strategies EXEL Trading Strategies for Exelixis Stock - Barchart.com trading strategies exel stock barchart https://www.epo.org/en/boards-of-appeal/decisions/t132115eu1 T 2115/13 (Azetidines/EXELIXIS) of 13.07.2018 2115 13 azetidines exelixis 07 https://www.barchart.com/stocks/quotes/EXEL/opinion/200-Day-Moving-Average/strategy-charts EXEL Barchart Opinion for Exelixis Stock - Barchart.com Trading Signals for Exelixis Inc with Buy, Sell, Hold recommendations, technical analysis, and trading strategy. exel barchart opinion stock https://www.barchart.com/stocks/quotes/EXEL/max-pain-chart EXEL Max Pain and Volatility Skew Charts for Exelixis Stock - Barchart.com Max Pain and Volatility Skew charts help options traders analyze trends and make better informed trade decisions. max pain volatility skew https://www.barchart.com/stocks/quotes/EXEL/overview EXEL - Exelixis Stock Price - Barchart.com Exelixis Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. stock price exel barchart https://www.barchart.com/stocks/quotes/EXEL/income-statement EXEL Income Statement for Exelixis Stock - Barchart.com Income Statement for Exelixis Inc (EXEL) with Annual and Quarterly reports. income statement exel stock barchart https://www.merck.com/bdl_item/exelixis-and-merck-sign-clinical-development-collaboration-to-evaluate-investigational-zanzalintinib-in-combination-with-keytruda-pembrolizumab-in-head-and-neck-cancer-and-in-combination-with/ Exelixis and Merck Sign Clinical Development Collaboration to Evaluate Investigational... Oct 14, 2024 - Exelixis, Inc. and Merck, known as MSD outside of the United States and Canada, announced that the companies have entered into a clinical development... clinical development exelixis merck sign collaboration https://www.barchart.com/stocks/quotes/EXEL/analyst-ratings EXEL Analyst Ratings for Exelixis Stock - Barchart.com Analyst Ratings for Exelixis Inc (EXEL) provide recommendations made by outside industry experts. analyst ratings exel stock barchart https://www.barchart.com/stocks/quotes/EXEL/opinion/100-Day-Moving-Average/strategy-charts EXEL Barchart Opinion for Exelixis Stock - Barchart.com Trading Signals for Exelixis Inc with Buy, Sell, Hold recommendations, technical analysis, and trading strategy. exel barchart opinion stock https://www.barchart.com/stocks/quotes/EXEL/vertical-spreads EXEL Bull Call Spread Options for Exelixis Stock - Barchart.com bull call spread exel options stock barchart https://www.barchart.com/stocks/quotes/EXEL/opinion/100-200-Day-MA-Crossover/strategy-charts EXEL Barchart Opinion for Exelixis Stock - Barchart.com Trading Signals for Exelixis Inc with Buy, Sell, Hold recommendations, technical analysis, and trading strategy. exel barchart opinion stock https://investingnews.com/exelixis-announces-first-quarter-2026-financial-results-and-provides-corporate-update/ Exelixis Announces First Quarter 2026 Financial Results and Provides Corporate Update | INN May 5, 2026 - - Total Revenues of $610.8 million, Cabozantinib Franchise U.S. Net Product Revenues of $555.0 million - - GAAP Diluted EPS of $0.79, Non-GAAP Diluted EPS of... first quarter 2026 financial results https://www.macrotrends.net/stocks/charts/EXEL/exelixis/ebitda Exelixis EBITDA 2012-2026 | EXEL | MacroTrends exelixis ebitda 2012 2026 macrotrends https://www.nasdaq.com/market-activity/stocks/exel/analyst-research Exelixis, Inc. Common Stock (EXEL) Analyst Research | Nasdaq Find the latest analyst research, reports, and ratings for Exelixis, Inc. Common Stock (EXEL) at Nasdaq.com. exelixis inc common stock analyst research nasdaq https://www.hotel-exelixis.com/ hotel-exelixis.com hotel exelixis https://www.fool.com/earnings/call-transcripts/2021/08/06/exelixis-inc-exel-q2-2021-earnings-call-transcript/ Exelixis, inc (EXEL) Q2 2021 Earnings Call Transcript | The Motley Fool Aug 6, 2021 - EXEL earnings call for the period ending June 30, 2021. earnings call transcript exelixis inc the motley q2 2021 https://www.biospace.com/exelixis-inc-announces-may-18-webcast-of-presentation-at-the-2006-bank-of-america-healthcare-conference Exelixis, Inc. Announces May 18 Webcast Of Presentation At The 2006 Bank of America Healthcare... https://www.fool.com/investing/2020/02/11/exelixis-reports-positive-results-in-metastatic-ca.aspx Exelixis Reports Positive Results in Metastatic Castration-Resistant Prostate Cancer Study | The... Feb 11, 2020 - Cabozantinib may help delay the need for chemotherapy in advanced patients. positive results https://www.biospace.com/exelixis-inc-to-release-fourth-quarter-and-full-year-2014-financial-results-on-tuesday-february-24-2015 Exelixis, Inc. To Release Fourth Quarter And Full Year 2014 Financial Results On Tuesday, February... https://www.barchart.com/stocks/quotes/EXEL/opinion/50-150-Day-MA-Crossover/strategy-charts EXEL Barchart Opinion for Exelixis Stock - Barchart.com Trading Signals for Exelixis Inc with Buy, Sell, Hold recommendations, technical analysis, and trading strategy. exel barchart opinion stock https://www.barchart.com/stocks/quotes/EXEL/butterfly-spreads EXEL Long Call Butterfly Options for Exelixis Stock - Barchart.com long call exel butterfly options stock https://finviz.com/quote?t=EXEL&ty=rv&ta=1&p=d EXEL - Exelixis Inc Revenue Breakdown EXEL - Exelixis Inc - Stock screener for investors and traders, financial visualizations. exelixis inc revenue breakdown https://www.biospace.com/exelixis-to-present-at-the-piper-sandler-35th-annual-healthcare-conference-on-november-28-2023 Exelixis to Present at the Piper Sandler 35th Annual Healthcare Conference on November 28, 2023 -... Nov 21, 2023 - Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare... https://www.barchart.com/stocks/quotes/EXEL/long-options EXEL Long Call Options for Exelixis Stock - Barchart.com long call exel options stock barchart https://www.barchart.com/stocks/quotes/EXEL/condor-strategies EXEL Long Call Condor for Exelixis Stock - Barchart.com long call exel condor stock barchart https://www.barchart.com/stocks/quotes/EXEL/options-flow EXEL Options Flow for Exelixis Stock - Barchart.com Largest options trades for Exelixis Inc (EXEL) options flow exel stock barchart https://builtin.com/company/exelixis/jobs Exelixis Jobs + Careers | Built In Explore jobs and careers at Exelixis. Exelixis is currently hiring for a range of positions. jobs careers exelixis built https://www.barchart.com/stocks/quotes/EXEL/straddles-strangles EXEL Long Straddle Options for Exelixis Stock - Barchart.com long straddle exel options stock barchart https://www.fool.com/earnings/call-transcripts/2020/08/07/exelixis-inc-exel-q2-2020-earnings-call-transcript.aspx Exelixis Inc (EXEL) Q2 2020 Earnings Call Transcript | The Motley Fool Aug 7, 2020 - EXEL earnings call for the period ending June 30, 2020. earnings call transcript exelixis inc q2 2020 the motley https://www.fool.com/investing/2016/06/06/why-transocean-exelixis-and-cf-industries-jumped-t.aspx Why Transocean, Exelixis, and CF Industries Jumped Today | The Motley Fool Jun 6, 2016 - These stocks helped lead the market higher. Find out why. cf industries the motley transocean exelixis https://www.businesswire.com/news/home/20230425006047/en/Exelixis-to-Release-First-Quarter-2023-Financial-Results-on-Tuesday-May-9-2023 Exelixis to Release First Quarter 2023 Financial Results on Tuesday, May 9, 2023 Exelixis, Inc. (Nasdaq: EXEL) announced today that its first quarter 2023 financial results will be released on Tuesday, May 9, 2023 after the markets close.... first quarter 2023 financial https://finviz.com/quote?t=EXEL&ty=dv EXEL - Exelixis Inc Dividends EXEL - Exelixis Inc - Stock screener for investors and traders, financial visualizations. exelixis inc dividends https://www.biospace.com/exelixis-inc-to-receive-milestone-payment-from-bristol-myers-squibb-for-achievement-of-liver-x-receptor-agonist-development-milestone Exelixis, Inc. to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X... https://www.businesswire.com/news/home/20210627005058/en/Exelixis-and-Ipsen-Announce-Cabozantinib-in-Combination-with-an-Immune-Checkpoint-Inhibitor-Significantly-Improved-Progression-Free-Survival-in-Phase-3-COSMIC-312-Pivotal-Trial-in-Patients-with-Previously-Untreated-Advanced-Liver-Cancer Exelixis and Ipsen Announce Cabozantinib in Combination with an Immune Checkpoint Inhibitor... Regulatory News: Exelixis, Inc. (NASDAQ: EXEL) and Ipsen (Euronext: IPN; ADR: IPSEY) today announced that COSMIC-312, the ongoing phase 3 pivotal trial evalu... https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/exelixis-nasdaqgsexel-reports-positive-phase-3-trial-results Exelixis (NasdaqGS:EXEL) Reports Positive Phase 3 Trial Results For Colorectal Cancer - Simply Wall... Exelixis (NasdaqGS:EXEL) recently announced positive topline results from the STELLAR-303 Phase 3 trial, highlighting the effectiveness of zanzalintinib in... https://www.24-7pressrelease.com/press-release/465335/blue-faery-welcomes-exelixis-to-its-corporate-council Blue Faery Welcomes Exelixis to its Corporate Council Oncology biotech company Exelixis becomes a founding member of Blue Faery's Benefactors Council blue faery welcomes exelixis corporate